Histone Deacetylase-3 Regulates the Expression of the Amyloid Precursor Protein and Its Inhibition Promotes Neuroregenerative Pathways in Alzheimer's Disease Models.

HDAC3 inhibition has been shown to improve memory and reduce amyloid-beta (A beta) in Alzheimer's disease (AD) models, but the underlying mechanisms are unclear. We investigated the molecular effects of HDAC3 inhibition on AD pathology, using in vitro and ex vivo models of AD, based on our finding that HDAC3 expression is increased in AD brains. For this purpose, N2a mouse neuroblastoma cells as well as organotypic brain cultures (OBCSs) of 5XFAD and wild-type mice were incubated with various concentrations of the HDAC3 selective inhibitor RGFP966 (0.1-10 mu M) for 24 h. Treatment with RGFP966 or HDAC3 knockdown in N2a cells was associated with an increase on amyloid precursor protein (APP) and mRNA expressions, without alterations in A beta 42 secretion. In vitro chromatin immunoprecipitation analysis revealed enriched HDAC3 binding at APP promoter regions. The increase in APP expression was also detected in OBCSs from 5XFAD mice incubated with 1 mu M RGFP966, without changes in A beta. In addition, HDAC3 inhibition resulted in a reduction of activated Iba-1-positive microglia and astrocytes in 5XFAD slices, which was not observed in OBCSs from wild-type mice. mRNA sequencing analysis revealed that HDAC3 inhibition modulated neuronal regenerative pathways related to neurogenesis, differentiation, axonogenesis, and dendritic spine density in OBCSs. Our findings highlight the complexity and diversity of the effects of HDAC3 inhibition on AD models and suggest that HDAC3 may have multiple roles in the regulation of APP expression and processing, as well as in the modulation of neuroinflammatory and neuroprotective genes. Our study demonstrates that inhibition of HDAC3 (in cell lines N2a cells or in brain organotypic cultures) or knockdown of HDAC3 in N2a cells leads to changes in gene transcription, involving an increase in APP expression (regulated by NCoR and other transcription factors) and on anti-inflammatory and regenerative genes, leading to an increase in synaptic spine density and a reduction in glial activation.image